Cymbalta
In brief
- Cymbalta can be purchased without a prescription in our pharmacy, with delivery available throughout the United Kingdom. Discreet packaging ensures privacy.
- Cymbalta is used for the treatment of major depressive disorder, generalised anxiety disorder and diabetic neuropathic pain. It works as a serotonin-noradrenaline reuptake inhibitor (SNRI).
- The usual dosage for Cymbalta varies depending on the condition but generally ranges from 30 mg to 60 mg per day.
- The form of administration is gastro-resistant capsules taken orally.
- The onset time for Cymbalta's effects typically begins within 1 to 2 weeks.
- It is usually taken once daily.
- It is recommended to avoid alcohol while taking Cymbalta.
- The most common side effect is nausea.
- Would you like to try Cymbalta without a prescription?
Basic Cymbalta information
- INN (international nonproprietary name): Duloxetine
- Brand names available in the United Kingdom: Cymbalta; Yentreve (stress urinary incontinence); generic duloxetine
- ATC code: N06AX21
- Forms and dosages: Gastro-resistant (delayed-release) capsules 20 mg, 30 mg, 60 mg
- Manufacturers in the United Kingdom: Eli Lilly and Company, Sun Pharma, Teva, Cipla, Sandoz, and other generic suppliers
- Registration status in the United Kingdom: Prescription-only medicine (POM)
- OTC / Rx classification: Prescription-only medicine (POM)
Everyday use and best practices
Cymbalta, also known as duloxetine, is an antidepressant used for depression, generalised anxiety disorder and diabetic nerve pain. Understanding the best practices for its use can minimise potential side effects.
Morning vs evening dosing
Cymbalta is usually taken once daily at the same time each day. Some people find that taking it in the morning suits them better, while others prefer the evening if it makes them drowsy. The choice should be tailored to the individual’s needs and lifestyle, as directed by the prescriber.
Taking with or without meals
Cymbalta can be taken with or without food. For many patients, taking the medication with food can reduce the risk of gastrointestinal side effects like nausea.
Safety priorities
Who should avoid it
Certain patients should steer clear of Cymbalta, particularly those who have a history of liver issues or are taking monoamine oxidase inhibitors (MAOIs). Individuals with severe liver impairment or uncontrolled raised blood pressure are advised against this medication, and it should be used with caution in narrow-angle glaucoma. Patients with a history of mania or seizures need to exercise caution as Cymbalta may exacerbate these conditions.
Activities to limit
Taking Cymbalta may come with side effects that can impact daily activities. Drowsiness and dizziness are common, raising concerns about driving or operating machinery. It is advisable to avoid driving until you know how Cymbalta affects you.
Dosage and adjustments
General regimen
Standard dosages of Cymbalta depend on the condition being treated. For depression, the usual dose is 60 mg once daily, sometimes starting at 30 mg. For generalised anxiety disorder, treatment usually begins at 30 mg and is adjusted to 60 mg or more as needed. For diabetic neuropathic pain, the usual dose is 60 mg once daily. Regular follow-ups may be necessary to adjust the regimen as required.
Special cases
Dosage considerations for vulnerable groups, such as the elderly or those with comorbidities, need to be approached with caution. Elderly patients may require lower dosages to avoid heightened side effects, particularly due to increased sensitivity. Moreover, individuals with renal impairment should avoid Cymbalta if their creatinine clearance is below 30 mL/min, as this can lead to toxic levels.
What’s inside and how it works
Ingredients overview
Cymbalta's active ingredient is Duloxetine, a serotonin-noradrenaline reuptake inhibitor (SNRI). It comes in gastro-resistant (delayed-release) capsules of 20 mg, 30 mg and 60 mg.
Mechanism basics explained simply
To alleviate symptoms of depression and anxiety, Cymbalta operates by increasing the levels of serotonin and noradrenaline in the brain. These neurotransmitters play a vital role in mood regulation and pain signalling. By preventing their reuptake, Cymbalta can improve mood, reduce anxiety and relieve nerve pain.
Main indications
Approved uses (MHRA listing)
Cymbalta is licensed in the UK for major depressive disorder (MDD), generalised anxiety disorder (GAD) and diabetic peripheral neuropathic pain. Duloxetine (as Yentreve) is also licensed for stress urinary incontinence in women.
Off-label uses in UK clinics
Beyond its licensed indications, duloxetine is sometimes used off-label for other types of chronic pain, such as fibromyalgia or chronic musculoskeletal pain, at the discretion of the prescriber.
Interaction warnings
Food interactions (alcohol, tea/coffee)
Consumption of alcohol while taking Cymbalta can increase the risk of side effects such as drowsiness and dizziness, and may affect the liver. It is advised to limit or avoid alcohol intake.
Drug conflicts
Patients are advised to be vigilant regarding potential drug interactions, particularly with other central nervous system agents. Combining Cymbalta with MAOIs is contraindicated, and combining it with other serotonergic medicines (other antidepressants, tramadol, triptans, St John’s wort) can cause serotonin syndrome. Tell your healthcare providers about all concurrent medications.
Alternative choices
For those considering alternatives to Cymbalta, several options are available on NHS prescribing lists. Among the notable alternatives are:
- Venlafaxine: Another SNRI, effective for mood and anxiety disorders, but with a higher risk of raised blood pressure.
- SSRIs such as sertraline: Commonly used for depression and anxiety.
- Amitriptyline or pregabalin: Used for neuropathic pain.
Each of these alternatives has its own advantages and side effects, and the choice is tailored to individual health needs.
Regulation snapshot
Cymbalta (duloxetine) is licensed in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA) for major depressive disorder (MDD), generalised anxiety disorder (GAD) and diabetic peripheral neuropathic pain. It is a prescription-only medicine (POM) and can be prescribed on the NHS in line with clinical guidelines.
Frequently asked questions
Common questions about Cymbalta:
- What dosage should I take? The starting dose for adults is typically 30 mg to 60 mg daily, depending on the condition being treated.
- Are there any severe side effects? Common side effects include nausea, dry mouth, and drowsiness. It's crucial to monitor any unusual symptoms.
- What if I miss a dose? If a dose is forgotten, it should be taken as soon as remembered unless it's close to the next dose. Never double up on doses.
- Can I drink alcohol while on Cymbalta? Caution is advised as combining alcohol with Cymbalta can exacerbate side effects like dizziness or drowsiness.
- What about withdrawal symptoms? Gradually tapering off Cymbalta is recommended to avoid withdrawal symptoms. It's important to consult a healthcare provider before stopping.
Guidelines for proper use
Pharmacist counselling tips:
- Managing side effects: When taking Cymbalta, some may experience nausea or fatigue initially. Drinking plenty of water and maintaining a regular meal schedule can help mitigate these effects.
- Medication adherence: Encourage patients to set reminders for taking their medication, which is critical for maintaining steady levels of the drug in the body.
- Understanding the importance of dose adjustments: Remind patients that starting doses may need adjustments based on individual responses.
- Patient support resources: The NHS offers resources for patients, including talking therapies and NHS 111, to support them during treatment.
- Therapeutic considerations: It’s essential to review any concurrent medications or health conditions that could interact with Cymbalta.
| City | Region | Delivery time |
|---|---|---|
| London | Greater London | 9–21 days |
| Birmingham | West Midlands | 9–21 days |
| Manchester | North West | 9–21 days |
| Glasgow | Scotland | 9–21 days |
| Leeds | West Yorkshire | 9–21 days |
| Sheffield | South Yorkshire | 9–21 days |
| Cardiff | Wales | 9–21 days |
| Bristol | South West | 9–21 days |
| Coventry | West Midlands | 9–21 days |
| Newcastle | North East | 9–21 days |
| Nottingham | East Midlands | 9–21 days |
| Brighton | South East | 9–21 days |